2017
DOI: 10.1101/cshperspect.a025262
|View full text |Cite
|
Sign up to set email alerts
|

Fosfomycin: Mechanism and Resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
184
1
4

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 241 publications
(194 citation statements)
references
References 56 publications
5
184
1
4
Order By: Relevance
“…Conversely, some genes have negative gene scores in only one or a handful of conditions. For example, consistent with earlier studies we found that overexpression of glpT or uhpT increases susceptibility to phosphomycin 57 . These results also agree with clinical data, which shows that the main cause of phosphomycin resistance in patients is the down-regulation of GlpT via down-regulation of cAMP.…”
Section: Resultssupporting
confidence: 93%
See 1 more Smart Citation
“…Conversely, some genes have negative gene scores in only one or a handful of conditions. For example, consistent with earlier studies we found that overexpression of glpT or uhpT increases susceptibility to phosphomycin 57 . These results also agree with clinical data, which shows that the main cause of phosphomycin resistance in patients is the down-regulation of GlpT via down-regulation of cAMP.…”
Section: Resultssupporting
confidence: 93%
“…These results also agree with clinical data, which shows that the main cause of phosphomycin resistance in patients is the down-regulation of GlpT via down-regulation of cAMP. 57 Accordingly, we also found that overexpression of cpdA (which encodes an enzyme that hydrolyzes cAMP) enhances fitness under phosphomycin stress ( Fig. 4 ).…”
Section: Resultsmentioning
confidence: 59%
“…Fosfomycin is a derivative of phosphonic acid that blocks an early stage in the synthesis of peptidoglycan, a component of the bacterial cell wall [41]. First discovered in 1969 [42], fosfomycin has recently received renewed interest for MDR Gram-negative bacteria.…”
Section: Contemporary Treatment Strategies For Gram-negative Vapmentioning
confidence: 99%
“…All the primers used were designed with Primer3 Input software; their specificity was tested by BLAST alignment against P. aeruginosa genome from Pseudomonas Genome Database (http://www.pseudomonas.com/) and their efficiency was analyzed by Real-time PCR using serial dilutions of cDNA. Differences in the relative amounts of mRNA were determined according to the 2 −ΔΔCT method (41, 42). In all cases, the values of relative mRNA expression were determined as the average of three independent biological replicates each one containing three technical replicates.…”
Section: Methodsmentioning
confidence: 99%